SYNEOS HEALTH

WIPO WIPO 2021

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke SYNEOS HEALTH wurde als Wortmarke am 03.06.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 29. Mai 2023

Markenform Wortmarke
Aktenzeichen 1617942
Länder Australien Brasilien Kanada Schweiz Kolumbien Europäische Gemeinschaft Großbritannien Indonesien Israel Indien Japan Südkorea Mexiko Malaysia Neuseeland Philippinen Russland Singapur Thailand Türkei Ukraine Vietnam
Basismarke US Nr. 90702195, 11. Mai 2021
Anmeldedatum 03. Juni 2021
Ablaufdatum 03. Juni 2031

Markeninhaber

1030 Sync Street
Morrisville NC 27560
US

Markenvertreter

P.O. Box 64807 Chicago IL 60664-0807 US

Waren und Dienstleistungen

35 Strategic business consulting, marketing and advertising, public relations communications strategy, information and data collection for business purposes, and business data analytics, namely, analyzing business data to understand and evaluate business performance, all of the aforementioned in the pharmaceutical, biotechnology and life sciences fields; sales promotion services; market analysis and research services; personnel recruitment and placement; recruitment services, namely, advertising clinical trials, recruiting patients, and placing patients for participation in clinical trials for testing of pharmaceuticals and devices; consulting in sales techniques and sales programs; sales volume tracking for others, all in the pharmaceutical, biotechnology and life sciences fields; business consulting in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; providing business assistance to pharmaceutical and biotechnology companies with applications for new drugs with governmental regulatory bodies; promoting the exchange of health information to promote patient adherence
41 Education in the field of pharmaceutical sales, namely, providing webinars, providing live workshops, providing on-line non-downloadable videos, providing on-line non-downloadable publications in the nature of articles and white papers, and production of podcasts; training services in the field of pharmaceutical sales; providing on-line non-downloadable newsletters and bulletins in the pharmaceutical, biotechnology and life sciences fields; educational services in the field of clinical trials, namely, providing on-line non-downloadable videos, webinars, live workshops, providing online non-downloadable publications in the nature of articles and white papers, and production of podcasts
42 Medical, scientific and data analysis research services for others, namely, conducting and analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; pharmaceutical drug development services, namely, developing clinical trial methodologies; consulting services in the area of pharmaceutical clinical testing; extended clinical research services for others, namely, computerized data management of clinical trials, biostatistical analysis, environmental consultancy, preclinical research and development evaluation, repairing flawed clinical trials and dossiers, strategic clinical research portfolio management, and biosurveillance monitoring; providing life science and scientific research information to physicians and other health care professionals, patients, and medical, pharmaceutical and biotechnology companies; providing regulatory compliant technical writing services in the field of medical research and clinical studies; consulting services in the field of contract clinical research and contract product development; Internet development, design and consulting services for others, namely, creating websites featuring blogs about medical and pharmaceutical information related to chronic illnesses and disease, creating an online community for patients and caregivers to communicate about healthcare, and design and development of interactive software for use in the communication and dissemination of medical and pharmaceutical information
44 Providing medical information to physicians, other health care professionals and for medical patients; providing health information regarding the medications and health care products of others, namely, product discontinuations, new formulations, bottle changes, and seasonal information through e-mail alerts and push notifications
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
10. Mai 2023 2023/21 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
14. April 2023 2023/15 Gaz PH RAW: Rule 18ter(2)(i) GP following a provisional refusal
03. April 2023 2023/14 Gaz MY Ablehnung
16. März 2023 2023/11 Gaz TH Ablehnung
19. Januar 2023 2023/3 Gaz CA Ablehnung
15. Dezember 2022 2022/51 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
25. Oktober 2022 2022/43 Gaz KR Ablehnung
04. Oktober 2022 2022/40 Gaz VN Ablehnung
23. September 2022 2022/39 Gaz ID Ablehnung
07. September 2022 2022/37 Gaz BR Ablehnung
29. August 2022 2022/35 Gaz IN Ablehnung
12. August 2022 2022/33 Gaz RU RAW: Rule 18ter(2)(ii) GP following a provisional refusal
12. August 2022 2022/33 Gaz CH Ablehnung
05. August 2022 2022/31 Gaz MX Ablehnung
21. Juli 2022 2022/29 Gaz JP Ablehnung
14. Juli 2022 2022/28 Gaz CO Ablehnung
06. Juli 2022 2022/27 Gaz UA Ablehnung
02. Mai 2022 2022/19 Gaz IL Ablehnung
25. März 2022 2022/13 Gaz NZ Ablehnung
01. März 2022 2022/10 Gaz SG Ablehnung
28. Februar 2022 2022/9 Gaz TR Ablehnung
24. Februar 2022 2022/8 Gaz EM Ablehnung
31. Januar 2022 2022/5 Gaz RU Ablehnung
26. Januar 2022 2022/4 Gaz GB Ablehnung
05. Januar 2022 2022/1 Gaz AU Ablehnung
19. Dezember 2021 2022/2 Gaz PH Ablehnung
03. Juni 2021 2021/38 Gaz US Eintragung

ID: 141617942